Exploring Mindsets, Beliefs and Resilience Across the Cancer Experience

Description

The goal of this clinical trial is to test the effect of digitally delivered programs on the health, wellbeing, and functioning of newly diagnosed cancer patients. Participants will be randomized to one of two digital programs. Both groups are equally important for the study. Participants will be asked to complete: * Questionnaires. Answers to the questionnaires will help the investigators understand how participants doing through the study. * Modules. Participants will receive access to digital courses developed by experts at Stanford University. * Blood Samples. At home blood collection kits will help the investigators understand how participants' bodies are responding over time. Kits will be sent and returned by mail.

Conditions

Cancer

Study Overview

Study Details

Study overview

The goal of this clinical trial is to test the effect of digitally delivered programs on the health, wellbeing, and functioning of newly diagnosed cancer patients. Participants will be randomized to one of two digital programs. Both groups are equally important for the study. Participants will be asked to complete: * Questionnaires. Answers to the questionnaires will help the investigators understand how participants doing through the study. * Modules. Participants will receive access to digital courses developed by experts at Stanford University. * Blood Samples. At home blood collection kits will help the investigators understand how participants' bodies are responding over time. Kits will be sent and returned by mail.

Changing Mindsets to Improve Whole Patient Health: a Randomized Controlled Trial of a Novel MHealth Intervention for People Diagnosed with Cancer

Exploring Mindsets, Beliefs and Resilience Across the Cancer Experience

Condition
Cancer
Intervention / Treatment

-

Contacts and Locations

Palo Alto

Stanford University, Palo Alto, California, United States, 94304

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Initial (non-recurrent) diagnosis of non-metastatic (stage I-III) or hematological malignancy.
  • * Diagnosis in the past 150 days.
  • * Currently receiving active systemic treatment or with a planned systemic treatment (including chemotherapy, immunotherapy or other targeted therapies).
  • * Eighteen years of age or older.
  • * Fluent in English.
  • * Currently reside in the United States.
  • * Access to a computer, tablet, or smartphone (a mobile phone that performs many of the functions of a computer, typically including a touchscreen interface, internet access, and an operating system capable of running downloaded applications, or tablet that runs iOS or Android software, with cellular data service or wifi access).
  • * Failure to meet inclusion criteria.
  • * Currently receiving treatment for severe depression, severe anxiety, bipolar disorder, post-traumatic stress disorder, or schizophrenia.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Alia J Crum, PhD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2028-01-30